​

VistaGen Therapeutics Ownership | Who Owns VistaGen Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

VistaGen Therapeutics Ownership Summary

VistaGen Therapeutics is owned by 6.01% institutional investors, 0.27% insiders, and 93.72% retail investors. Orbimed advisors is the largest institutional shareholder, holding 9.58% of VTGN shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 4.43% of its assets in VistaGen Therapeutics shares.

VTGN Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockVistaGen Therapeutics6.01%0.27%93.72%
SectorHealthcare Stocks 232.20%10.74%-142.94%
IndustryBiotech Stocks 382.11%10.55%-292.66%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Orbimed advisors3.06M9.58%$10.86M
Tcg crossover management2.68M8.38%$9.50M
Stempoint capital lp2.49M7.79%$7.75M
Vanguard group1.82M5.10%$1.21M
Commodore capital lp1.57M4.93%$5.59M
Ikarian capital620.87K1.94%$2.20M
Jane street group527.13K1.47%$348.90K
Blackrock funding, inc. /de422.76K1.18%$279.82K
Diadema partners lp349.79K1.10%$1.24M
Geode capital management352.84K0.99%$233.60K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Stempoint capital lp2.49M1.55%$7.75M
Tcg crossover management2.68M0.47%$9.50M
Diadema partners lp349.79K0.32%$1.24M
Commodore capital lp1.57M0.27%$5.59M
Orbimed advisors3.06M0.26%$10.86M
Ikarian capital620.87K0.22%$2.20M
Almitas capital261.40K0.21%$927.97K
Persistent asset partners75.32K0.18%$267.38K
Adar1 capital management113.06K0.04%$401.37K
Advisorshares investments250.19K0.03%$165.60K

Top Buyers

HolderShares% AssetsChange
Orbimed advisors3.06M0.26%3.06M
Jane street group527.13K0.00%224.44K
Two sigma investments, lp289.41K0.00%199.96K
Vanguard group1.82M-137.00K
Two sigma advisers, lp157.03K0.00%131.20K

Top Sellers

HolderShares% AssetsChange
Nantahala capital management---1.98M
Soleus capital management---550.00K
Sphera funds management---447.94K
Adar1 capital management113.06K0.04%-307.70K
Jpmorgan chase16.00--271.81K

New Positions

HolderShares% AssetsChangeValue
Orbimed advisors3.06M0.26%3.06M$10.86M
Xtx topco69.71K0.01%69.71K$247.48K
Occudo quantitative strategies lp42.70K0.02%42.70K$151.60K
Hrt financial lp37.59K0.00%37.59K$24.00K
Quadrature capital15.75K0.00%15.75K$55.76K

Sold Out

HolderChange
Barclays-1.00
Sjs investment consulting-100.00
Cwm-582.00
Bfsg-1.00K
Royal bank of canada-3.30K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20256-90.77%2,147,851-90.81%60.11%3-91.18%3-66.67%
Sep 30, 202515-71.70%2,473,487-84.03%70.33%3-87.50%4-63.64%
Jun 30, 2025536.00%15,493,303-1.24%481.86%2578.57%10-52.38%
Mar 31, 202551-16.39%15,943,0802.72%512.03%15-54.55%2066.67%
Dec 31, 20246115.09%15,520,6051.70%502.04%3394.12%12-7.69%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard US Total Market Shares ETF1.28M4.43%-
Vanguard Total Stock Mkt Idx Inv1.16M2.93%-
Biotech Growth Ord808.70K2.04%-
Vanguard Institutional Extnd Mkt Idx Tr413.75K1.04%-
AdvisorShares Psychedelics ETF277.11K0.70%-
Fidelity Extended Market Index199.37K0.50%47.53K
BlackRock Extended Equity Market K61.89K0.23%-26.00
A4Investments SICAV SIF ACCI IlanaA2EURH60.00K0.22%-
iShares Micro-Cap ETF78.95K0.20%78.95K
DFA US Small Cap I74.27K0.19%23.73K

Recent Insider Transactions

DateNameRoleActivityValue
Aug 07, 2023COMMODORE CAPITAL LP-Buy$17.96M
Aug 18, 2022GIN JERRY B Buy$17.87K
Aug 17, 2022Adler Reid G. CHIEF LEGAL OFFICERBuy$50.91K
Aug 17, 2022Singh Shawn CHIEF EXECUTIVE OFFICERBuy$103.20K
Jul 12, 2022Shah Nimish P Sell$53.40K

Insider Transactions Trends

DateBuySell
2025 Q3--
2025 Q2--
2024 Q4--
2024 Q3--
2024 Q2--

VTGN Ownership FAQ

Who Owns VistaGen Therapeutics?

VistaGen Therapeutics shareholders are primarily institutional investors at 6.01%, followed by 0.27% insiders and 93.72% retail investors. The average institutional ownership in VistaGen Therapeutics's industry, Biotech Stocks , is 382.11%, which VistaGen Therapeutics falls below.

Who owns the most shares of VistaGen Therapeutics?

VistaGen Therapeutics’s largest shareholders are Orbimed advisors (3.06M shares, 9.58%), Tcg crossover management (2.68M shares, 8.38%), and Stempoint capital lp (2.49M shares, 7.79%). Together, they hold 25.76% of VistaGen Therapeutics’s total shares outstanding.

Does Blackrock own VistaGen Therapeutics?

BlackRock is not among the top 10 institutional shareholders of VistaGen Therapeutics.

Who is VistaGen Therapeutics’s biggest shareholder by percentage of total assets invested?

Stempoint capital lp is VistaGen Therapeutics’s biggest shareholder by percentage of total assets invested, with 1.55% of its assets in 2.49M VistaGen Therapeutics shares, valued at 7.75M$.

Who is the top mutual fund holder of VistaGen Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of VistaGen Therapeutics shares, with 4.43% of its total shares outstanding invested in 1.28M VistaGen Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools